J. Stanton

发表

Synthesis and biological activity of some transition-state inhibitors of human renin.

J. Wood, P. Bühlmayer, L. Criscione, 1988, Journal of medicinal chemistry.

Synthesis and anticonvulsant activity of some tetracyclic indole derivatives.

M. H. Ackerman, J. Stanton, 1983, Journal of medicinal chemistry.

Inhibitors of renin as potential therapeutic agents.

J. Wood, K. Hofbauer, J. Stanton, 1987, Journal of enzyme inhibition.

Synthesis and biological activity of phenoxyphenyl oxamic acid derivatives related to L-thyronine.

J. Wasvary, J. Stanton, R. Dotson, 2000, Bioorganic & medicinal chemistry letters.

The effect of heteroatom substitution on a series of phosphonate inhibitors of neutral endopeptidase 24.11

G. Ksander, Reynalda de Jesus, J. Stanton, 1994 .

Synthesis and structure-activity relationships of oxamic acid and acetic acid derivatives related to L-thyronine.

A. Engle, J. Wasvary, J. Stanton, 1995, Journal of medicinal chemistry.

Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors.

J. Stanton, D. Sperbeck, R. Ghai, 1993, Journal of medicinal chemistry.

CGP 38 560: Orally Active, Low‐Molecular‐Weight Renin Inhibitor with High Potency and Specificity

J. Wood, J. Kay, M. de Gasparo, 1989, Journal of cardiovascular pharmacology.

Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives.

J. Stanton, J. Slade, G. Mazzenga, 1985, Journal of medicinal chemistry.

Angiotensin Converting Enzyme Inhibitors: 1,5‐Benzothiazepine Derivatives.

J. Stanton, J. Slade, G. Mazzenga, 1986 .

Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives.

J. E. Babiarz, M. H. Ackerman, J. Stanton, 1983, Journal of Medicinal Chemistry.

Synthesis and biological properties of (carboxyalkyl)amino-substituted bicyclic lactam inhibitors of angiotensin converting enzyme.

J. E. Babiarz, J. Stanton, M. Desai, 1985, Journal of medicinal chemistry.

Angiotensin converting enzyme inhibitors: structure-activity profile of 1-benzazepin-2-one derivatives.

J. E. Babiarz, J. Stanton, H. Tomaselli, 1985, Journal of medicinal chemistry.

Dibenzodiazepines and other Tricyclic Diazepine Systems

J. Stanton, J. Watthey, J. L. Stanton, 1985 .

Some aspects of terpene biosynthesis—a model

B. Trost, J. Stanton, P. Conway, 1971 .

The synthesis of pyridine derivatives from 3‐formylchromone

A. Sprecher, J. Stanton, G. Haas, 1981 .

Substituted chromenes as potent, orally active 5-lipoxygenase inhibitors.

T. Kowalski, Y. Satoh, J. Stanton, 1993, Journal of medicinal chemistry.

An enantioconvergent approach to prostanoids

B. Trost, J. Stanton, J. Timko, 1978 .

Angiotensin converting enzyme inhibitors: 1-glutarylindoline-2-carboxylic acids derivatives.

C. F. Huebner, L. Browne, F. H. Ebetino, 1983, Journal of medicinal chemistry.

ANGIOTENSIN CONVERTING ENZYME INHIBITORS: N-SUBSTITUTED MONOCYCLIC AND BICYCLIC AMINO ACID DERIVATIVES

J. E. Babiarz, M. H. Ackerman, J. Stanton, 1984 .

Anilides of (R)-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.

W. H. Wang, G R Bebernitz, T D Aicher, 2000, Journal of medicinal chemistry.

Secondary amides of (R)-3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid as inhibitors of pyruvate dehydrogenase kinase.

T D Aicher, J L Stanton, J Gao, 2000, Journal of medicinal chemistry.

Perhydroquinolylbenzamides as novel inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.

A. Jeng, P. Kukkola, J. Stanton, 2005, Journal of medicinal chemistry.